New Drug Approved to Treat ADHD

The new drug Vyvanse received approval on Monday by the Food and Drug Administration to affectively treat Attention Deficit Hyperactivity Disorder. Although the medication received approval, it will come with a black box warning due to the possible side affects of the amphetamine contained in the medication. The drug is manufactured by Shire PLC, the manufacturer of the current blockbuster ADHD medication Aderall XR. According to HealthDay, “The wire service quotes Shire spokesman Matt Cabrey as saying that the company has tested Vyvanse on adults who have a history of stimulant abuse to assess its "likeability." The outcome, according to Shire, was that Vyvanse delays the intensity of amphetamine effects, which include increased alertness, physical activity, and d View the rest of this article